US 8110352
Method of diagnosing and treating cancer using B-catenin splice variants
granted A61PA61P35/00A61P43/00
Quick answer
US patent 8110352 (Method of diagnosing and treating cancer using B-catenin splice variants) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P43/00